The purpose of the study is to evaluate safety and tolerability of 4SC-203 after a single dose administration in healthy volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
60
Charité Research Organisation
Berlin, Germany
Investigation of safety and tolerability of escalating single doses of 4SC-203.
Time frame: 14 days
To investigate the pharmacokinetics of single doses of 4SC-203.
Time frame: 14 days
To assess the pharmacodynamic effect by means of appropriate biomarkers.
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.